SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-059684
Filing Date
2023-12-26
Accepted
2023-12-26 16:32:40
Documents
1
Period of Report
2023-12-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1580
  Complete submission text file 0001209191-23-059684.txt   3163
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL PHARMACEUTICALS INC (Issuer) CIK: 0001445499 (see all company filings)

IRS No.: 263058238 | State of Incorp.: DE | Fiscal Year End: 0426
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O IMPEL PHARMACEUTICALS INC. 201 ELLIOTT AVENUE WEST, SUITE 260 SEATTLE WA 98119
Business Address
Smith Brandon D (Reporting) CIK: 0002005266 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40353 | Film No.: 231513697